Fidelity Investments
RUBY

Fidelity Investments’s Rubius Therapeutics, Inc RUBY Stock Holding History

Fidelity Investments’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12,376,153
Closed -$2.13M – 5633
2022
Q4 		$2.13M Sell
12,376,153
-1,081,346
-8% -$295K ﹤0.01% 2357
2022
Q3 		$5.84M Sell
13,457,499
-71,426
-0.5% -$53.5K ﹤0.01% 2112
2022
Q2 		$11.5M Buy
13,528,925
+932
+0% +$1.56K ﹤0.01% 1906
2022
Q1 		$74.5M Buy
13,527,993
+48,127
+0.4% +$306K 0.01% 1205
2021
Q4 		$130M Sell
13,479,866
-47,627
-0.4% -$660K 0.01% 985
2021
Q3 		$242M Hold
13,527,493
– – 0.02% 724
2021
Q2 		$330M Hold
13,527,493
– – 0.03% 613
2021
Q1 		$358M Buy
13,527,493
+2,149,226
+19% +$31.4M 0.03% 550
2020
Q4 		$86.4M Buy
11,378,267
+1,150,742
+11% +$6.83M 0.01% 1097
2020
Q3 		$51.2M Sell
10,227,525
-214,370
-2% -$1.14M 0.01% 1179
2020
Q2 		$62.4M Buy
10,441,895
+459,724
+5% +$2.71M 0.01% 1073
2020
Q1 		$44.4M Buy
9,982,171
+814,879
+9% +$6.05M 0.01% 1077
2019
Q4 		$87.1M Buy
9,167,292
+1,349,662
+17% +$13.1M 0.01% 963
2019
Q3 		$61.4M Buy
7,817,630
+244,970
+3% +$2.85M 0.01% 1078
2019
Q2 		$119M Buy
7,572,660
+552,930
+8% +$8.92M 0.01% 847
2019
Q1 		$127M Buy
7,019,730
+573,662
+9% +$8.8M 0.02% 801
2018
Q4 		$101M Buy
6,446,068
+219,304
+4% +$4M 0.01% 846
2018
Q3 		$141M Buy
+6,226,764
New +$142M 0.02% 794

Other funds holding RUBY

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return

Fidelity Investments's RUBY Position: Q1 2023 in Review

Fidelity Investments sold out of Rubius Therapeutics, Inc (RUBY) in Q1 2023, closing a stake of 12,376,153 shares — an estimated $2.13M sold.

Fidelity Investments first reported a position in RUBY in Q3 2018 and held it in 18 quarters. The position peaked at $358M in Q1 2021. 7 funds tracked by Wall St. Rank hold RUBY as of Q1 2023.

  • Fidelity Investments reported no remaining Rubius Therapeutics, Inc position as of Q1 2023 after selling out during the quarter.
  • Fidelity Investments sold 12,376,153 Rubius Therapeutics, Inc shares in Q1 2023, an estimated $2.13M.
  • Fidelity Investments first reported a position in Rubius Therapeutics, Inc in Q3 2018 and held it in 18 quarters.
  • Fidelity Investments's Rubius Therapeutics, Inc position peaked at $358M in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q1 2023.

Based on Fidelity Investments's 13F filing for Q1 2023, filed 11 May 2023.